The dynamics of the Norovirus Treatment Market Share are currently defined by a duality: a mature, fragmented segment dominated by supportive care providers and a nascent, concentrated segment vying for the future high-value therapeutic share. In the immediate, existing market, the Share is distributed among numerous manufacturers of generic and over-the-counter products, including...